In this update we are covering the news stories from November 2023, keeping you informed whether you are managing your own diabetes or doing so as a carer.
TYPE 1 SCREENING FOR ADULTS
T1D HEALTH SECRETARY APPOINTED BY UK GOVERNMENT
The new Health Secretary appointed for UK Government in today's reshuffle (13 November 2023), Victoria Atkins has type 1 diabetes. The MP for Louth and Horncastle, in Lincolnshire, she was diagnosed at the age of 3 years, although interestingly she is married to the MD of British Sugar. We wait to see if either of these facts will have any impact on policies relating to diabetes!
NICE ANNOUNCES HYBRID CLOSED LOOP RECOMMENDED FOR TYPE 1s
All type 1s under 18 year olds will be eligible, as will all T1D pregnant women and those planning a pregnancy. For other adults, the criteria states that they must have tried to manage the condition with a cgm first, or suffer disabling hypoglycaemia and their HbA1c is 7.5% or greater.
Find out about Hybrid Closed Loops in our blog here.
LATEST NHS AUDIT FIGURES RELEASED
According to theNational Diabetes Audit 2021-22 for England and Wales, published 12 October 2023, there are 270,935 people in England and 16,090 people in Wales living with type 1 diabetes. Of these, 37.4% were reported to have a HbA1c of less than 7.5%.
To see the Audit in more detail click here.
NEW MuLT1verse STORY FOR WDD
The 5th issue of the popular Type 1 series of comics from Revolve Comics in collaboration with NHS diabetes specialists from Portsmouth & Southampton, was released this month for World Diabetes Day. Issue 4 is called Secret Wards and is an adventure involving safety in hospitals for those with diabetes.
All issues are free to read online or download. Clickhere to find out more.
TRESIBA PEN SHORTAGE
LEVEMIR TO BE DISCONTINUED IN US BY END OF 2024
Novo Nordisk have announced that they will stop production of Levemir in the US by the end of 2024. The company stated that there are likely to be intermittent delays to distribution and this may affect markets, and patients ability to get this type of insulin, outside of the US.
Read more about this here.
DIABETES RESEARCH D-CODED
A new tool has been launched which aims to demystify diabetes research. Founded by the Diabesties Foundation, a non-profit organisation based in India, the aim is to "simplify complex research studies about Diabetes, and to make science accessible to everyone living with the condition".
Partha Kar (NHS Co-lead for Diabetes in England) is one of the Advisors involved in the project.
Read more about this news here.
NEW SIBIONICS CGM GETS CE MARK
A new option for continuous glucose monitoring is set to launch in the UK and Europe, following a CE mark being awarded to Sibionics GS1 CGM.
Sibionics are the world's 3rd largest CGM company, based in China.
Click here to see Sibionics website.
THE TIME TO TACKLE RISING TYPE 2 IS T2DaY
The latest NHS patient data on diabetes shows that there are now more 18-40 year olds with type 2 diabetes than the total number of those with type 1, in England.
A recent article by Partha Kar, Co-lead for Diabetes, NHS England, published in the bmj, explains that these figures represent the fact that around 4% of people with type 2 diabetes are now under 40. However, the rise of 18% in the last 5 years is worrying in several ways and notably it identifies how disproportionately type 2 affects people already at risk of health inequalities.
A programme dedicated to under 40's - the world's first of this kind - is now being rolled out called 'T2Day: Type 2 Diabetes in the Young’.
Click here for more information.
ABBOTT LOSES CASE AGAINST DEXCOM
Blogs and publications on this website are independent of any involvement by medtech companies or diabetes related charities. To ensure there is no bias, we do not accept any products, freebies or other material from any medtech provider. Except where credited otherwise, all materials are copyright ©️Love My Libre Ltd.
Love My Libre is not associated or affiliated with Abbott or FreeStyle Libre. Content here and on our website www.lovemylibre.com does not constitute medical advice or replace the relationship between you and healthcare professionals nor the advice you receive from them.
The author of this blog has type 1 diabetes and uses the FreeStyle Libre 2 which is provided on NHS prescription.